Mohamed A H Ahmed, MD, PhD, FRCPath

1.7K posts

Mohamed A H Ahmed, MD, PhD, FRCPath banner
Mohamed A H Ahmed, MD, PhD, FRCPath

Mohamed A H Ahmed, MD, PhD, FRCPath

@MoAhmedMD

Consultant Histopathologist. NHS. UK: Uropathologist, lead of Uropathology NNUHFT#Norfolk and Norwich University hospital, UK

United Kingdom Katılım Şubat 2011
1.1K Takip Edilen823 Takipçiler
Janira Navarro
Janira Navarro@Janiranavarro·
Histopathologic Flavors of Metastatic Prostate Carcinoma - Undifferentiated 🔷 High-grade carcinoma 🔷 Typically NKX3.1/AR negative. Neuroendocrine markers can be spotty/nonspecific. NGS can be helpful in reaching the diagnosis of prostate origin. Dr. Chan #USCAP2026 #pathology #PathX #PathTwitter
Janira Navarro tweet mediaJanira Navarro tweet media
English
1
16
36
1.7K
Mohamed A H Ahmed, MD, PhD, FRCPath
@slusagar @kriyer68 @garreyf If you do include them in your biopsy report, what is the direct clinical implication? Do surgeons make sure to take more tissue around the apex in those particular cases? You do mention it then in the tumour board/ MDT?
English
0
0
0
29
Ankur Sangoi
Ankur Sangoi@slusagar·
@garreyf great question! while apical skel muscle does NOT constitute EPE as you well know, there is lit 👇🏼saying it should be reported (risk of + apical margin at RP) in our group, we do include presence/absence of this in our synoptic summary table for prostate bx
Ankur Sangoi tweet media
English
2
10
30
1.2K
Garrey Faller
Garrey Faller@garreyf·
Prostate apex core needle biopsy. Does this finding require a more careful apical dissection if a radical prostatectomy is performed ? ie should we ever report? @slusagar
Garrey Faller tweet media
English
4
11
49
4.3K
Mohamed A H Ahmed, MD, PhD, FRCPath retweetledi
Ankur Sangoi
Ankur Sangoi@slusagar·
#GUpath nephrectomy: Dx: clear cell papillary renal cell tumor (I wish they'd named it clear cell TUBULOPAPILLARY renal tumor to emphasize morph!) here,😍example of "shark smile" (tubulopapillary morph)🔬, as some cases lack prominent "reverse-apical" nuclei!
Ankur Sangoi tweet mediaAnkur Sangoi tweet mediaAnkur Sangoi tweet mediaAnkur Sangoi tweet media
English
1
20
38
1.9K
Mohamed A H Ahmed, MD, PhD, FRCPath retweetledi
Ankur Sangoi
Ankur Sangoi@slusagar·
#GUpath #grosspath nephrectomy with central scar: DDx: oncocytoma, chromophobe RCC...but also LOT! 🔬compact nests, loose cord-like nests floating in stroma, lymphocytic aggregates 🎨pos CK7/GATA3/L1CAM, neg CD117/CK20, retained SDHB 🧪another entity in TSC/MTOR family
Ankur Sangoi tweet mediaAnkur Sangoi tweet mediaAnkur Sangoi tweet mediaAnkur Sangoi tweet media
English
1
17
50
2.1K
Mohamed A H Ahmed, MD, PhD, FRCPath retweetledi
Andres Matoso
Andres Matoso@Andres_Matoso·
Frozen section of paratesticular mass. Characteristic features include dilated channels simulating vessels and prominent smooth muscle stroma and cells with cytoplasmic vacuoles. Right FS diagnosis saves the testis. #gupath #urology
Andres Matoso tweet mediaAndres Matoso tweet mediaAndres Matoso tweet media
English
21
78
187
0
Mohamed A H Ahmed, MD, PhD, FRCPath retweetledi
Springer Pathology
Springer Pathology@SpringerPath·
A study in Virchows Archiv examines GPNMB immunohistochemistry in TFEB-altered renal cell carcinomas (RCCs). All 25 cases showed GPNMB positivity, indicating its potential as a sensitive screening marker for these tumors. bit.ly/4sja0oG
English
0
6
8
427
Mohamed A H Ahmed, MD, PhD, FRCPath retweetledi
Yale Pathology
Yale Pathology@yalepathology·
Join us for the annual William Barriss McAllister, Jr., Memorial Lecture @YaleMed on Thurs., March 5 at 12:30 PM ET as @JLHornick of @HarvardMed & @BrighamWomens, presents on, “Beyond Lineage: Diagnostic & Predictive Molecular Immunohistochemistry” shorturl.at/e5Aj9
Yale Pathology tweet media
English
1
17
40
4.8K
Mohamed A H Ahmed, MD, PhD, FRCPath retweetledi
Andres Matoso
Andres Matoso@Andres_Matoso·
Large Nested Urothelial Carcinoma on H&E 🔬 Deceptively bland cytology with expansile, well-circumscribed nests infiltrating the lamina propria—an architectural wolf in sheep’s clothing. Recognition is critical to avoid underdiagnosis of this aggressive variant. #Pathology
Andres Matoso tweet media
English
0
29
87
3.2K
Lara Harik MD
Lara Harik MD@LaraHarikMD·
Can you make the diagnosis of TFE3 rearranged rcc on needle biopsy? Yes!: 1) if you think about it and 2) are lucky to have enough tissue! (confirmed NONO:TFE3) TFE3 IHC is not perfect but can be helpful as part of a screening panel #GUPATH #pathology #pathres #kidneycancer
Lara Harik MD tweet mediaLara Harik MD tweet mediaLara Harik MD tweet mediaLara Harik MD tweet media
English
3
13
44
2.1K
Mohamed A H Ahmed, MD, PhD, FRCPath retweetledi
Lara Harik MD
Lara Harik MD@LaraHarikMD·
#Kidney biopsy, ⚠️unusual case (v rare) 70 yo male ⚡️notice 2 morphologically distinct areas IHC and answer 👇 #rare #GUPATH #pathology #pathres
Lara Harik MD tweet mediaLara Harik MD tweet mediaLara Harik MD tweet mediaLara Harik MD tweet media
English
2
10
30
2.2K
Mohamed A H Ahmed, MD, PhD, FRCPath retweetledi
C. Christofer Juhlin
C. Christofer Juhlin@DrJuhlin·
In primary aldosteronism, HISTALDO may overcall non-classical cases, missing curable resections. A simple “B2 ratio” (size of dominant vs 2nd-largest nodule) boosts accuracy and predicts surgical success. Better diagnosis = better outcomes. @EJEndo academic.oup.com/ejendo/advance…
C. Christofer Juhlin tweet media
English
1
10
31
1.8K
Mohamed A H Ahmed, MD, PhD, FRCPath retweetledi
Ankur Sangoi
Ankur Sangoi@slusagar·
#GUpath folks assessing🔬non-neoplastic kidney of renal tumor nephrectomy
English
3
6
40
3.8K